Published in Drug Week, March 16th, 2007
"The aim of this study was to further investigate the discriminatory ability of the HoNOS; criterion validity was also examined....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.